Abstract
Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug in the treatment of rheumatoid arthritis (RA). MTX neurotoxicity in an RA population is uncommon, with few case reports describing this phenomenon.1-3
Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug in the treatment of rheumatoid arthritis (RA). MTX neurotoxicity in an RA population is uncommon, with few case reports describing this phenomenon.1-3
